Enanta Pharma (NASDAQ: ENTA) reported Q1 EPS of ($0.42), $0.39 better than the analyst estimate of ($0.81). Revenue for the quarter came in at $18.6 million versus the consensus estimate of $16.05 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.